Products
HER2/ErbB2 antibody
Category:
Research Area:
Synonyms: | CD340 antibody, ERBB2 antibody, HER 2 antibody, HER 2/neu antibody, HER2 antibody, MLN 19 antibody, MLN19 antibody, NEU antibody, NGL antibody, p185 antibody, p185erbB2 antibody, Proto oncogene c ErbB 2 antibody, Proto oncogene Neu antibody, TKR1 antibody | ||
Catalogue No.: | FNab03834 | Reactivity: | Human |
Host: | Rabbit | Tested Application: | ELISA, WB, IHC, IF |
Clonality: | polyclonal | Isotype: | IgG |
- SPECIFICATIONS
- Product Name
- HER2/ErbB2 antibody
- Catalogue No.
- FNab03834
- Size
- 100μg
- Form
- liquid
- Purification
- Immunogen affinity purified
- Purity
- ≥95% as determined by SDS-PAGE
- Clonality
- polyclonal
- Isotype
- IgG
- Storage
- PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
- Immunogen
- v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog(avian)
- Alternative Names
- CD340 antibody, ERBB2 antibody, HER 2 antibody, HER 2/neu antibody, HER2 antibody, MLN 19 antibody, MLN19 antibody, NEU antibody, NGL antibody, p185 antibody, p185erbB2 antibody, Proto oncogene c ErbB 2 antibody, Proto oncogene Neu antibody, TKR1 antibody
- UniProt ID
- P04626
- Observed MW
- 185 kDa
Application
- Tested Applications
- ELISA, WB, IHC, IF
- Recommended dilution
- WB: 1:500-1:2000; IHC: 1:20-1:200; IF: 1:20-1:200
Validated Images
HeLa cells were subjected to SDS PAGE followed by western blot with FNab03834(ERBB2 antibody) at dilution of 1:500
Immunohistochemistry of paraffin-embedded human breast cancer using FNab03834(ERBB2 antibody) at dilution of 1:50
Immunofluorescent analysis of HeLa cells using FNab03834 (ErbB2 antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG(H+L)
- Background
- This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors.